Analysis of treatment outcomes in patients with progressive locally advanced non-resectable and disseminated medullary thyroid cancer receiving vandetanib outside of clinical trials (Russian experience)
The study objective is to perform retrospective analysis of the efficacy and safety of vandetanib for metastatic and non-resectable medullary thyroid cancer in routine clinical practice. Materials and methods. We analyzed treatment outcomes in 46 patients treated with vandetanib. We also evaluated p...
Saved in:
| Main Authors: | I. S. Romanov, А. М. Mudunov, S. О. Podvyaznikov, А. V. Ignatova, Yu. V. Alymov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2020-07-01
|
| Series: | Опухоли головы и шеи |
| Subjects: | |
| Online Access: | https://ogsh.abvpress.ru/jour/article/view/526 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Disseminated medullary thyroid carcinoma. Optimal approach to treatment
by: I. S. Romanov, et al.
Published: (2019-01-01) -
THE DIAGNOSIS AND TREATMENT OF MEDULLARY THYROID CANCER
by: V. Zh. Brzhezovsky, et al.
Published: (2015-04-01) -
MEDULLARY THYROID CARCINOMA
by: V. S. Medvedev, et al.
Published: (2015-04-01) -
Medullary thyroid cancer in combination with autoimmune thyroiditis after COVID-19
by: E. V. Ryabchenko
Published: (2022-06-01) -
Familial Clinical Heterogeneity of Medullary Thyroid Cancer with Germline RET S891A Protooncogene Mutation: 7-year Follow-up with Successful Sorafenib Treatment
by: Sirmen Kızılcan Çetin, et al.
Published: (2025-09-01)